Amprenavir
-
Catalog numberB2141-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameN-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid, (3S)-tetrahydro-3-furanyl ester; VX-478
-
DescriptionAmprenavir is the active metabolite of the pro-drug fosamprenavir. It acts as an antiretroviral HIV Protease Inhibitor. When used alone or in combination therapy with other antiretroviral agents, amprenavir decreases viral load and increases CD4+ cell counts.
-
CAS Number161814-49-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₅H₃₅N₃O₆S
-
Molecular Weight505.63
-
Cell PermeableYes
-
Purity≥95% by HPLC
-
SolubilitiesDMSO (~20 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA HIV Protease Inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00934214
-
PubChem CID65016
-
SMILESCC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
-
InChiInChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1
-
InChi KeyYMARZQAQMVYCKC-OEMFJLHTSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameAmprenavir
-
Alternative nameAmprenavir
-